Bliss GVS Pharma Control Transfers to Anupam Rasayan

Summary of Key Information:

Reporting Period (Quarter/Year): Not Applicable

Nature of Filing / Announcement: Regulatory filing pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 regarding outcomes of the Board Meeting

Audit Opinion:

Not Specified

Auditor’s Comment:

Not Specified

Key Financial Highlights:

Not Specified

Standalone Results:

Not Specified

Consolidated Results:

Not Specified

Segment-wise Performance:

Not Specified

Corporate Actions:

A change in control and promoter status was completed. Mates Visa Consultancy Private Limited (PAC) acquired 5,09,84,595 equity shares, representing 47.95% of the equity share capital of Bliss GVS Pharma Limited. Together with 1,669 equity shares acquired by Anupam Rasayan India Limited under the Open Offer, the consortium holds an aggregate of 5,09,86,264 equity shares, representing 47.95% of the equity share capital. This acquisition was completed pursuant to a share purchase agreement dated May 23, 2026, and a deed of adherence dated July 17, 2026. Effective September 28, 2026, Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited have become the 'Promoters' of the Company.

Other Significant Information:

The transaction was governed by a Share Purchase Agreement (SPA) dated May 23, 2026, among Anupam Rasayan India Limited (Purchaser), the Sellers (including Mr. S. N. Kamath as Seller 1), and a Deed of Adherence dated July 17, 2026, executed with Mates Visa Consultancy Private Limited (PAC).

#BlissGVSPharma #AnupamRasayan #ChangeInControl #ManagementChange #M&A